InsiderTradr

Krebs Biochemicals & Industries Limited (KREBSBIO.BO)

BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic

₹59.65 (-6.18%) as of

Key statistics

Market cap
1.29B
EPS (TTM)
-6.54
Dividend yield
0.00%
52-week range
38.52 – 76.72
Beta
0.90
Revenue (TTM)
252.34M
Profit margin
-55.85%
Volume
10.81k

About Krebs Biochemicals & Industries Limited

Krebs Biochemicals & Industries Limited engages in the manufacture of active pharmaceutical ingredients in India. It offers androstenedione for steroid intermediate indications, as well as lovastatin and simvastatin for anti-cholesterol applications. The company also develops amlodipine and telmisartan for anti-hypertension; cetirizine for antihistamine; orlistat for anti-obesity; serratiopeptidase for anti-inflammatory; and phenylephrine for cold and cough. In addition, it provides contract manufacturing services for large pharmaceutical and multinational companies. The company was incorporated in 1991 and is based in Visakhapatnam, India.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Headquarters
Visakhapatnam, India
Employees
142

krebsbiochem.com

Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.

Related stocks